152 related articles for article (PubMed ID: 12193530)
1. A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.
Lim H; Dey SK
Endocrinology; 2002 Sep; 143(9):3207-10. PubMed ID: 12193530
[TBL] [Abstract][Full Text] [Related]
2. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.
Lim H; Gupta RA; Ma WG; Paria BC; Moller DE; Morrow JD; DuBois RN; Trzaskos JM; Dey SK
Genes Dev; 1999 Jun; 13(12):1561-74. PubMed ID: 10385625
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
Gupta RA; Tan J; Krause WF; Geraci MW; Willson TM; Dey SK; DuBois RN
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13275-80. PubMed ID: 11087869
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors.
Kubis N; Levy BI
J Mol Cell Cardiol; 2004 Mar; 36(3):331-2. PubMed ID: 15010271
[No Abstract] [Full Text] [Related]
5. Characterization of the PGI2/IP system in cultured rat mesangial cells.
Nasrallah R; Landry A; Scholey JW; Hébert RL
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):455-64. PubMed ID: 15062848
[TBL] [Abstract][Full Text] [Related]
6. Human fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and synthesize abundant PGI.
Huang JC; Arbab F; Tumbusch KJ; Goldsby JS; Matijevic-Aleksic N; Wu KK
J Clin Endocrinol Metab; 2002 Sep; 87(9):4361-8. PubMed ID: 12213900
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferators-activated receptor δ (PPARδ) promotes blastocyst hatching in mice.
Kang HJ; Hwang SJ; Yoon JA; Jun JH; Lim HJ; Yoon TK; Song H
Mol Hum Reprod; 2011 Oct; 17(10):653-60. PubMed ID: 21511721
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.
Majed BH; Khalil RA
Pharmacol Rev; 2012 Jul; 64(3):540-82. PubMed ID: 22679221
[TBL] [Abstract][Full Text] [Related]
9. Implications of the molecular basis of prostacyclin biosynthesis and signaling in pharmaceutical designs.
Ruan KH; Dogné JM
Curr Pharm Des; 2006; 12(8):925-41. PubMed ID: 16533160
[TBL] [Abstract][Full Text] [Related]
10. Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.
Cutler NS; Graves-Deal R; LaFleur BJ; Gao Z; Boman BM; Whitehead RH; Terry E; Morrow JD; Coffey RJ
Cancer Res; 2003 Apr; 63(8):1748-51. PubMed ID: 12702555
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin receptor signaling and early embryo development in the mouse.
Huang JC; Wun WS; Goldsby JS; Egan K; FitzGerald GA; Wu KK
Hum Reprod; 2007 Nov; 22(11):2851-6. PubMed ID: 17905746
[TBL] [Abstract][Full Text] [Related]
12. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
13. PPAR delta functions as a prostacyclin receptor in blastocyst implantation.
Lim H; Dey SK
Trends Endocrinol Metab; 2000; 11(4):137-42. PubMed ID: 10754535
[TBL] [Abstract][Full Text] [Related]
14. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
Ikawa H; Kameda H; Kamitani H; Baek SJ; Nixon JB; Hsi LC; Eling TE
Exp Cell Res; 2001 Jul; 267(1):73-80. PubMed ID: 11412039
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.
Shao J; Sheng H; DuBois RN
Cancer Res; 2002 Jun; 62(11):3282-8. PubMed ID: 12036946
[TBL] [Abstract][Full Text] [Related]
16. Concomitant activation of functionally opposing prostacyclin and thromboxane prostanoid receptors by cyclo-oxygenase-1-mediated prostacyclin synthesis in mouse arteries.
Liu B; Luo W; Zhang Y; Li H; Zhang J; Tan XR; Zhou Y
Exp Physiol; 2012 Jul; 97(7):895-904. PubMed ID: 22447972
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin potenciates PGI(2) release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL.
Martínez-González J; Escudero I; Badimon L
Atherosclerosis; 2004 Jun; 174(2):305-13. PubMed ID: 15136060
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin IP receptor up-regulates the early expression of C/EBPbeta and C/EBPdelta in preadipose cells.
Aubert J; Saint-Marc P; Belmonte N; Dani C; Négrel R; Ailhaud G
Mol Cell Endocrinol; 2000 Feb; 160(1-2):149-56. PubMed ID: 10715548
[TBL] [Abstract][Full Text] [Related]
20. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.
Tong BJ; Tan J; Tajeda L; Das SK; Chapman JA; DuBois RN; Dey SK
Neoplasia; 2000; 2(6):483-90. PubMed ID: 11228540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
